High lysosomal activities in cystic fibrosis tracheal gland cells corrected by adenovirus-mediated CFTR gene transfer

被引:2
作者
Kammouni, W
Naïmi, D
Renaud, W
Bianco, N
Figarella, C
Merten, MD
机构
[1] Fac Med Marseille, Grp Rech Glandes Exocrines, F-13385 Marseille 05, France
[2] Univ Constantine, Inst Sci Nat, Physiol Lab, Constantine, Algeria
[3] Hop Enfants La Timone, Dept Pathol & Neuropathol, Marseille, France
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 1999年 / 1453卷 / 01期
关键词
airways; lung; submucosa; gene therapy; cell culture;
D O I
10.1016/S0925-4439(98)00084-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human tracheal gland serous (HTGS) cells are now believed to be a major target of cystic fibrosis (CF) gene therapy. To evaluate the efficiency of adenovirus-mediated gene transfer in these cells we tested the adenovirus construction containing beta-galactosidase cDNA. We observed that the endogenous beta-galactosidase activity in cultured CF-HTGS cells was too strong to allow us to detect any exogenous beta-galactosidase activity. Immunohistological study on sections of human tracheal tissue confirmed the presence of beta-galactosidase in the serous component of the submucosal glands. We then looked for other lysosomal activities in normal and CF-HTGS cells. We showed that normal cells already have elevated enzyme values and that CF-HTGS cells contained 2-4-fold more beta-galactosidase, alpha-fucosidase, alpha-mannosidase and beta-glucuronidase activities than normal cells. An analysis of their kinetic constants has shown that this difference could be attributed to a lower K-m of CF lysosomal enzymes. More importantly, these differences are eliminated after adenovirus-mediated CFTR gene transfer and not after beta-galactosidase gene transfer. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:14 / 22
页数:9
相关论文
共 30 条
[1]  
ALAWQATI Q, 1992, J EXP BIOL, V172, P245
[2]   ACTIVITY LEVELS AND PROPERTIES OF ACID ALPHA-GLUCOSIDASE FROM LIVER AND NEUTRAL ALPHA-GLUCOSIDASE FROM SERA OF CYSTIC-FIBROSIS PATIENTS AND CONTROLS [J].
ALHADEFF, JA ;
THOM, D ;
HOLZINGER, RT .
CLINICA CHIMICA ACTA, 1981, 117 (02) :227-237
[3]   DEFECTIVE ACIDIFICATION OF INTRACELLULAR ORGANELLES IN CYSTIC-FIBROSIS [J].
BARASCH, J ;
KISS, B ;
PRINCE, A ;
SAIMAN, L ;
GRUENERT, D ;
ALAWQATI, Q .
NATURE, 1991, 352 (6330) :70-73
[4]  
BASBAUM CB, 1990, ANNU REV PHYSIOL, V52, P97
[5]   CHARACTERIZATION OF CAMP-DEPENDENT CFTR-CHLORIDE CHANNELS IN HUMAN TRACHEAL GLAND-CELLS [J].
BECQ, F ;
MERTEN, MD ;
VOELCKEL, MA ;
GOLA, M ;
FIGARELLA, C .
FEBS LETTERS, 1993, 321 (01) :73-78
[6]   Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: A phase I clinical trial [J].
Bellon, G ;
MichelCalemard, L ;
Thouvenot, D ;
Jagneaux, V ;
Poitevin, F ;
Malcus, C ;
Accart, N ;
Layani, MP ;
Aymard, M ;
Bernon, H ;
Bienvenu, J ;
Courtney, M ;
Doring, G ;
Gilly, B ;
Gilly, R ;
Lamy, D ;
Levrey, H ;
Morel, Y ;
Paulin, C ;
Perraud, F ;
Rodillon, L ;
Sene, C ;
So, S ;
TouraineMoulin, F ;
Schatz, C ;
Pavirani, A .
HUMAN GENE THERAPY, 1997, 8 (01) :15-25
[7]  
BOUT A, 1994, GENE THER, V1, P385
[8]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[9]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[10]  
Dorin JR, 1996, GENE THER, V3, P797